We are thrilled to announce Patricia Brown's appointment as our new Vice President of Marketing. With her extensive experience in healthcare and proven leadership skills, Tricia will play a crucial role in advancing our marketing initiatives and driving the growth of our commercial portfolio in critical care and infectious diseases.

Cardiovascular disease continues to be a leading cause of death worldwide. The dedicated efforts of cardiovascular professionals are essential for managing and improving outcomes for patients with this condition. We extend our gratitude to everyone involved, from nurses to cardiologists, cardiothoracic surgeons to rehabilitation specialists. Thank you for your unwavering commitment. #cardiovascular #cardiothoracic #hearthealth

We are proud to sponsor this educational resource provided by @SIDP, which reviews the updated SIS management guidelines for intra-abdominal infections (IAIs). We appreciate this contribution and all the other resources offered by SIDP to support best practices and enhance patient care. You can check it out here: #SIDP #infectiousdiseases #intraabdominalinfections

Congratulations to our global partners, @ZaiLab_Global on launching our targeted antibiotic XACDURO® (sulbactam-durlobactam for Injection) in China. We are proud to contribute to the fight against a World Health Organization-identified growing global health threat and a high-priority pathogen.

We are proud to support @ERASCardiac whose efforts focus on improving the perioperative care of cardiac surgical patients. We look forward to seeing you at ERAS events during this year's Society of Thoracic Surgeons (STS) Annual Meeting, January 24-26, in Los Angeles. #STS2025 #perioperativecare #cardiovascularcriticalcare #septicshock #ICUpatients

Join us at this year’s Society of Thoracic Surgeons Annual Meeting in Los Angeles, January 24-26. We look forward to meeting with healthcare providers to discuss recent advances in managing perioperative vasoplegia and the therapeutic role of angiotensin II. #STS2025 #thoracicsurgeons #criticalcare

Acute Kidney Injury (AKI) is common in patients with distributive shock. A new post-hoc analysis of the pivotal ATHOS-3 trial shares new insights on angiotensin II use in patients with AKI. Read the abstract here:

We’re excited to attend the American Society of Transplant Surgeons Winter Symposium to learn of the latest clinical advances and gather insights on the management of drug-resistant infections and vasoplegic shock, two critical issues often experienced in patients who have recently undergone transplant surgery. We hope to see you in Phoenix. #ASTS2025 #transplantsurgery #innovation

Acinetobacter is one of the most multi-drug resistant organisms affecting hospitalized patients in critical care for extended periods. This recent study investigates the dosing of sulbactam-durlobactam in patients with Carbapenem-resistant Acinetobacter baumannii (CRAB) who require continuous renal replacement therapy (CRRT). Read more here:

We celebrate the invaluable leadership of pharmacists in delivering optimal care to patients in critical care and infectious diseases. Your expertise and dedication drive the success of healthcare teams everywhere. Happy National Pharmacist Day!

Warmest wishes for a joyful holiday season from all of us at Innoviva Specialty Therapeutics! 🎄✨ May your days be filled with peace, happiness, and cheer. Happy Holidays! 🎁🌟 hashtag#SeasonOfJoy #HolidayGreetings

We're excited to connect with pharmacy professionals from around the world at the ASHP Midyear Clinical Meeting & Exhibition! Visit us at booth #859 to discover how we're supporting hospital pharmacists with innovative therapeutic solutions. We look forward to seeing you there! @ASHPOfficial #ASHP24

We are working with our development partners, Global Antibiotic R&D Partnership (GARDP), to address the growing concern of drug-resistant gonorrhea, the second most prevalent bacterial sexually transmitted infection in the United States. The CDC and WHO have raised alerts regarding ceftriaxone-resistant Neisseria gonorrhoeae and its potential impact on public health in the U.S. and worldwide. Learn more at

Each year in the United States, over 2.8 million antimicrobial-resistant infections occur, leading to more than 35,000 deaths, according to the CDC's Antibiotic Resistance (AR) Threats Report. This highlights the critical importance of recognizing U.S. Antibiotic Awareness Week (USAAW). The week aims to raise awareness about the responsible use of antibiotics and the increasing threat of antimicrobial resistance. #ISTX #CDC #USAAW2024

This week, we invite you to support the CDC’s efforts to raise awareness about the proper use of antibiotics to help combat antibiotic resistance in the U.S. and around the world. As a leader in antibiotic drug development, we understand the importance of using existing antibiotics judiciously while also investing in the development of new therapies to address these infections. #Antimicrobialresistance, #CDC, #USAAW2024

We are incredibly proud that our pathogen-targeting antibiotic, XACDURO®, was nominated for the 2024 Best Biotechnology Product of the Year. Congratulations to all the winners and nominees of the Prix Galien USA!

We look forward to discussing the management of distributive shock in perioperative and cardiothoracic care. Will we see you there? #ISTX #STSA

On Monday, November 4, Prix Galien USA Awards Committee members and nominees for the Prix Galien Best Biotechnology Product Award will discuss the therapeutic and industrial challenges they faced while successfully bringing life-changing innovations to market. For more information, please visit #prixgalien

We are excited to announce Michalene Bauer's appointment as Vice President of Sales and Market Access. Michalene’s proven leadership and therapeutic area expertise will play a pivotal role in driving awareness and access to our innovative therapeutics in critical care and infectious diseases medicine.